NDT Advance Access originally published online on January 8, 2009
Nephrology Dialysis Transplantation 2009 24(3):1063-1064; doi:10.1093/ndt/gfn726
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
About the effect of low-molecular-weight heparin on platelet function in haemodialysis patients
E-mail: teleftheriadis@yahoo.com
| The first 10% of the full text of this article appears below. |
Sir,
We read the recently published study by Gritters et al. that evaluated the role of the extracorporeal circuit (ECC) and of the low-molecular-weight heparin (LMWH) in platelet (PLT) activation. Using the PLT surface marker CD62p, they concluded that various parts of ECC are responsible for PLT activation
1 Department of Nephrology General Hospital of Serres, Serres 2 Department of Nephrology University Hospital of Larissa Larissa, Greece